Citigroup’s Medline Inc MDLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.85M Sell
255,154
-3,988
-2% -$146K ﹤0.01% 1725
2026
Q2
$10.2M Sell
259,142
-51,772
-17% -$2.09M ﹤0.01% 1602
2026
Q1
$13.8M Buy
310,914
+163,598
+111% +$7.22M 0.01% 1276
2025
Q4
$6.19M Buy
+147,316
New +$6.22M ﹤0.01% 1865

Other funds holding MDLN

Citigroup's MDLN Position: Q3 2026 in Review

Citigroup reduced its Medline Inc (MDLN) stake by 1.5% in Q3 2026, selling an estimated $146K and leaving 255,154 shares worth $8.85M. The position accounts for ﹤0.01% of the portfolio, ranked #1725.

Citigroup first reported a position in MDLN in Q4 2025 and has held it in 4 quarters since. The position peaked at $13.8M in Q1 2026. 136 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

  • Citigroup held 255,154 shares of Medline Inc worth $8.85M as of Q3 2026.
  • Citigroup sold 3,988 Medline Inc shares in Q3 2026, an estimated $146K.
  • Medline Inc made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #1725 holding.
  • Citigroup first reported a position in Medline Inc in Q4 2025 and has held it in 4 quarters since.
  • Citigroup's Medline Inc position peaked at $13.8M in Q1 2026.
  • 136 funds tracked by Wall St. Rank held Medline Inc as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.